IDENTIFICATION OF GENETICALLY HOMOZYGOUS RAPID AND SLOW ACETYLATORS OF DRUGS AND ENVIRONMENTAL CARCINOGENS AMONG ESTABLISHED INBRED RABBIT STRAINS

  • 1 January 1982
    • journal article
    • research article
    • Vol. 223  (1) , 40-44
Abstract
Liver and gut mucosa N-acetyltransferase (NAT) [EC 2.3.1.-] cytosol (105,000 .times. g) was prepared from selected lines of New Zealand White rapid and slow acetylator rabbits, and from inbred and partially inbred rabbits. Liver NAT activity was determined with p-aminobenzoic acid, p-aminosalicyclic acid, procainamide, sulfamethazine, isoniazid and 2-aminofluorene as substrates. Gut mucosal NAT activity was determined with 2-aminofluorene. A gene dose-response relationship was observed for both liver NAT and gut mucosa NAT with all substrates tested. Highest levels were always observed in homozygous rapid acetylator inbred strains (B/J, III/J, IIIC/J, III/DwJ, IIIEP/J and IIIVO/J), lower levels in obligate heterozygous rapid acetylator rabbits and lowest levels in homozygous slow acetylator inbred (ACEP/J, III/cdJ, IIIVO/ahJ and IIIVO/vptJ) and outbred rabbits. The differences in magnitude of liver NAT activity level between acetylator genotypes was dependent on the substrate employed, progressively increasing in the following order: p-aminobenzoic acid, p-aminosalicyclic acid, procainamide, sulfamethazine, isoniazid, 2-aminofluorene. The determination of kinetic constants for liver p-aminosalicyclic acid NAT activity indicated a 2-fold difference in apparent Vmax between rapid acetylator genotypes and a 30-fold difference between rapid and slow acetylator phenotypes. The apparent Km for p-aminosalicyclic acid was significantly lower in the slow acetylators than in the rapid acetylators.